Vanguard Group
ERB

Vanguard Group’s ERBA DIAGNOSTICS ERB Stock Holding History

Vanguard Group’s Portfolio ERB Stock Details ERB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-300,358
Closed -$240K – 4112
2016
Q2 		$240K Hold
300,358
– – ﹤0.01% 3913
2016
Q1 		$306K Sell
300,358
-350
-0.1% -$422 ﹤0.01% 3884
2015
Q4 		$418K Buy
300,708
+2,100
+0.7% +$3.5K ﹤0.01% 3877
2015
Q3 		$591K Buy
298,608
+2,600
+0.9% +$5K ﹤0.01% 3802
2015
Q2 		$649K Buy
296,008
+400
+0.1% +$1.19K ﹤0.01% 3791
2015
Q1 		$1.04M Buy
295,608
+8,821
+3% +$30.9K ﹤0.01% 3622
2014
Q4 		$909K Buy
286,787
+1,266
+0.4% +$3.74K ﹤0.01% 3558
2014
Q3 		$1M Buy
285,521
+4,831
+2% +$13.7K ﹤0.01% 3509
2014
Q2 		$553K Buy
280,690
+29,570
+12% +$53.2K ﹤0.01% 3654
2014
Q1 		$645K Buy
251,120
+68,490
+38% +$202K ﹤0.01% 3586
2013
Q4 		$511K Buy
182,630
+2,849
+2% +$5.42K ﹤0.01% 3591
2013
Q3 		$259K Hold
179,781
– – ﹤0.01% 3660
2013
Q2 		$153K Buy
+179,781
New +$140K ﹤0.01% 3676

Other funds holding ERB

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

Vanguard Group's ERB Position: Q3 2016 in Review

Vanguard Group sold out of ERBA DIAGNOSTICS (ERB) in Q3 2016, closing a stake of 300,358 shares — an estimated $240K sold.

Vanguard Group first reported a position in ERB in Q2 2013 and held it in 13 quarters. The position peaked at $1.04M in Q1 2015. 2 funds tracked by Wall St. Rank hold ERB as of Q3 2016.

  • Vanguard Group reported no remaining ERBA DIAGNOSTICS position as of Q3 2016 after selling out during the quarter.
  • Vanguard Group sold 300,358 ERBA DIAGNOSTICS shares in Q3 2016, an estimated $240K.
  • Vanguard Group first reported a position in ERBA DIAGNOSTICS in Q2 2013 and held it in 13 quarters.
  • Vanguard Group's ERBA DIAGNOSTICS position peaked at $1.04M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held ERBA DIAGNOSTICS as of Q3 2016.

Based on Vanguard Group's 13F filing for Q3 2016, filed 14 Nov 2016.